Helmy Eltoukhy

Helmy Eltoukhy serves as Chairman and Co-Chief Executive Officer at Guardant Health, leading efforts to innovate in the field of liquid biopsies and transform cancer into a manageable disease. In addition, Helmy Eltoukhy is a member of the Board of Directors at Paradromics Inc. and a member of the Board of Trustees at the SETI Institute. Previously, Helmy Eltoukhy held significant roles at Illumina as Sr. Director of Advanced Technology Group and Director of Scientific Research, focusing on groundbreaking sequencing technologies and systems. Other leadership experience includes serving as President and CEO of Avantome and conducting postdoctoral research at the Stanford Genome Technology Center. Helmy Eltoukhy has a robust educational background with a PhD, MS, and BS in Electrical Engineering from Stanford University.